Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones

被引:70
作者
Gonzales, E [1 ]
Chen, HZ [1 ]
Munuve, R [1 ]
Mehrani, T [1 ]
Britten-Webb, J [1 ]
Nadel, A [1 ]
Alam, HB [1 ]
Wherry, D [1 ]
Burris, D [1 ]
Koustova, E [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Surg, Trauma Res & Readiness Inst Surg, Bethesda, MD 20814 USA
来源
SHOCK | 2006年 / 25卷 / 04期
关键词
valproic acid; hemorrhagic shock; gene expression; histone code; histone deacetylase; hyperacetylation; survival;
D O I
10.1097/01.shk.0000209522.28120.c8
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Pharmacological inhibitors of histone deacetylases (HDAC) demonstrate cytoprotective effects both in vitro and in vivo. In this study, we investigated whether valproic acid (VPA), a known mood stabilizer and anticonvulsant with HDAC-inhibiting activity, improves survival following otherwise lethal hemorrhage in rats. We found that preinsult injection of VPA (300 mg/kg, twice) prolonged the survival of severely hypotensive animals up to 5 times. VPA treatment increased the acetylation of nonhistone and histone proteins in the rat heart. The pattern of modifications of individual histones revealed hyperacetylation of histones H2A, H3, and H4, indicating the presence of active genes. Expression of HSP70 and superoxide dismutase, implicated in the modulation of vitality, was increased by VPA. Our results reveal that VPA offers considerable protection in the hemorrhagic shock model and suggest a role for HDAC inhibition in mediating VPA actions.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 38 条
[1]
cDNA array analysis of gene expression following hemorrhagic shock and resuscitation in rats [J].
Alam, HB ;
Stegalkina, S ;
Rhee, P ;
Koustova, E .
RESUSCITATION, 2002, 54 (02) :195-206
[2]
Gene activation by histone and factor acetyltransferases [J].
Berger, SL .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) :336-341
[3]
Genomewide studies of histone deacetylase function in yeast [J].
Bernstein, BE ;
Tong, JK ;
Schreiber, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (25) :13708-13713
[4]
Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3β in the regulation of HSF-1 activity [J].
Bijur, GN ;
Jope, RS .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2401-2408
[5]
Anti-tumor mechanisms of valproate: A novel role for an old drug [J].
Blaheta, RA ;
Cinatl, J .
MEDICINAL RESEARCH REVIEWS, 2002, 22 (05) :492-511
[6]
Valproate and valproate-analogues: Potent tools to fight against cancer [J].
Blaheta, RA ;
Nau, H ;
Michaelis, M ;
Cinatl, J .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (15) :1417-1433
[7]
Regulation of lifespan by histone deacetylase [J].
Chang, KT ;
Min, KT .
AGEING RESEARCH REVIEWS, 2002, 1 (03) :313-326
[8]
Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster [J].
Chen, T ;
Sun, H ;
Lu, J ;
Zhao, YM ;
Tao, D ;
Li, XX ;
Huang, BQ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 408 (02) :171-176
[9]
Histone deacetylases (HDACs): characterization of the classical HDAC family [J].
De Ruijter, AJM ;
Van Gennip, AH ;
Caron, HN ;
Kemp, S ;
Van Kuilenburg, ABP .
BIOCHEMICAL JOURNAL, 2003, 370 :737-749
[10]
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium [J].
De Sarno, P ;
Li, XH ;
Jope, RS .
NEUROPHARMACOLOGY, 2002, 43 (07) :1158-1164